BSECompany Update7 Aug 2026 · 7 Aug 2026, 09:01 pm
As enclosed
Aarti Pharmalabs Ltd · 543748
✦ AI SummaryMgmt Change
Aarti Pharmalabs Ltd has informed that Mr. Rajendra Vallabhaji Gogri, a non-executive director, will not seek re-appointment as a director of the company due to personal goals and other commitments.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Directorate
Attachments (1)
📄pdf
Download →
ce22639a-3b88-4479-b97f-6fe1784b4c8d.pdf
View document text
August 07, 2026
To, To,
Listing/ Compliance Department Listing/ Compliance Department
BSE LTD. National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1,
Dalal Street, G Block, Bandra Kurla Complex,
Mumbai - 400 001 Bandra (E), Mumbai – 400 051
SCRIP CODE: 543748 SYMBOL: AARTIPHARM
Dear Sir/Madam,
Ref: Regulation 30 of SEBI (LODR)
Regulations, 2015
We wish to inform you that Mr. Rajendra Vallabhaji Gogri (DIN: 00061003), Non-Executive
Director, who is liable to retire by rotation at the ensuing Annual General Meeting (AGM)
of the Company has informed that, due to personal goals and other commitments, he does
not offer himself for re-appointment as a Director of the Company. Accordingly, his tenure
as Director of the Company shall continue up to the date of the ensuing AGM (close of
business hours).
Please take the same on your records.
Thanking you,
Yours faithfully,
For AARTI PHARMALABS LIMITED
JEEVAN MONDKAR
COMPANY SECRETARY AND LEGAL HEAD
ICSI M. NO. A22565